We are independently owned and the opinions expressed here are our own
How These Results Compare to Other Weight Loss Medicines Retatrutide's 24.2% mean weight loss at 48 weeks exceeds phase 3 data for semaglutide 2.4 mg (~14.9% at 68 weeks) and is comparable to tirzepatide 15 mg (~22.5% at 72 weeks), though no direct head-to-head trials have been conducted
How Much Compensation Can You Get in an Ozempic, Wegovy, or Rybelsus Settlement for Gastroparesis/Stomach Paralysis
Based on the available data, short-term effects related to MT-I and MT-II consist of the following [5, 18]: Nausea Facial flushing Fatigue Dizziness In addition, clinical studies on MT-II have reported several other specific side effects [19, 23]: Yawning Stretching Spontaneous erections Prolonged, painful erections (priapism) The administration of MT-I and MT-II can rarely cause reactions at the injection site, such as redness, swelling, and bleeding